home / stock / beam / beam quote
Last: | $21.38 |
---|---|
Change Percent: | -0.65% |
Open: | $21.74 |
Close: | $21.38 |
High: | $21.95 |
Low: | $21.11 |
Volume: | 1,172,517 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$21.38 | $21.74 | $21.38 | $21.95 | $21.11 | 1,172,517 | 04-26-2024 |
$21.6 | $22 | $21.6 | $22.5499 | $20.84 | 1,742,568 | 04-25-2024 |
$22.74 | $23.56 | $22.74 | $23.85 | $22.63 | 1,031,807 | 04-24-2024 |
$23.47 | $24.04 | $23.47 | $25.4699 | $23.44 | 1,182,324 | 04-23-2024 |
$24.1 | $24.27 | $24.1 | $24.27 | $23.205 | 2,434,712 | 04-22-2024 |
$23.9 | $24.14 | $23.9 | $24.94 | $23.64 | 4,536,965 | 04-19-2024 |
$24.31 | $24.19 | $24.31 | $24.78 | $24.05 | 1,714,242 | 04-18-2024 |
$24.31 | $26.06 | $24.31 | $26.14 | $24.14 | 1,443,197 | 04-17-2024 |
$25.7 | $25.23 | $25.7 | $25.9 | $24.84 | 1,676,103 | 04-16-2024 |
$25.7 | $26.2 | $25.7 | $26.415 | $25.14 | 2,234,343 | 04-15-2024 |
$25.93 | $26.99 | $25.93 | $26.99 | $25.52 | 1,299,267 | 04-12-2024 |
$27.27 | $27.49 | $27.27 | $27.515 | $26.67 | 1,069,247 | 04-11-2024 |
$27.06 | $27.52 | $27.06 | $27.69 | $26.69 | 3,283,951 | 04-10-2024 |
$29.32 | $28.86 | $29.32 | $29.34 | $28.2 | 776,406 | 04-09-2024 |
$28.81 | $28.36 | $28.81 | $28.86 | $28.01 | 850,406 | 04-08-2024 |
$28.2 | $28.51 | $28.2 | $28.74 | $28.03 | 1,506,125 | 04-05-2024 |
$29.03 | $29.75 | $29.03 | $30.12 | $28.9 | 944,402 | 04-04-2024 |
$29.68 | $30.18 | $29.68 | $30.72 | $29.59 | 1,165,546 | 04-03-2024 |
$30.55 | $30.65 | $30.55 | $31 | $30.0015 | 1,896,107 | 04-02-2024 |
$32.66 | $32.9 | $32.66 | $32.99 | $31.61 | 1,016,806 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Beam Therapeutics Inc. Company Name:
BEAM Stock Symbol:
NASDAQ Market:
Popular pseudonymous crypto analyst Altcoin Sherpa on Friday shared his insights on three altcoins: Beam (CRYPTO: BEAM), Arbitrum (CRYPTO: ARB), an...
2024-04-02 20:15:01 ET Citigroup analyst issues BUY recommendation for BEAM on April 2, 2024 07:14PM ET. The previous analyst recommendation was Buy. BEAM was trading at $30.55 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...
Verve Therapeutics Inc (NASDAQ:VERV) announced an update from the Heart-1 Phase 1b trial of VERVE-101. VERVE-101 is being evaluated in pa...